Acetide 500 Tablet contains Acetazolamide 500mg, a well-established carbonic anhydrase inhibitor commonly used in managing glaucoma, fluid retention, certain seizure types, and altitude-related conditions. Its pharmacological action helps reduce intraocular pressure and minimize excess fluid accumulation.
The tablet ensures reliable absorption and consistent therapeutic activity, making it suitable for both ophthalmic and systemic medical applications. Its proven effectiveness and long-standing clinical usage make it a dependable choice in specialized care.
For suppliers, Acetide 500 is a steady-demand product in ophthalmology, nephrology, and neurology segments. Since it serves multiple treatment needs, distributors can expect strong and recurring orders from clinics, hospitals, and specialty centers.
Offering Acetide 500 enables partners to strengthen their presence in niche therapeutic markets, expand their product basket with a versatile formulation, and build a consistent revenue stream through high-utility, prescription-driven sales.
Possible side effects include tingling sensations in hands/feet, frequent urination, loss of appetite, nausea, altered taste, or fatigue. Rarely, electrolyte imbalance, kidney stones, severe rash, or blood cell abnormalities may occur.
Acetide 500 Tablet is indicated for glaucoma (to reduce intraocular pressure), epilepsy (as adjunct therapy), altitude sickness prevention/treatment, idiopathic intracranial hypertension, and certain edema conditions. It supports pressure reduction and fluid balance.
Use only under medical supervision. Not recommended in patients with severe kidney or liver disease, electrolyte imbalance, sulfonamide allergy, or adrenal insufficiency. Adequate hydration is advised. Do not self-adjust the dose.
Store in a cool, dry place below 25°C, protected from light and moisture. Keep out of reach of children.